<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="53" height="12" font="1">Sep 26, 2011</text>
<text top="359" left="94" width="415" height="12" font="1">Mouse monoclonal IgG, raised against amino acids 191-300 of recombinant RUNX3 of human origin.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="102" height="12" font="1">fpauli@hudsonalpha.org</text>
<text top="134" left="83" width="61" height="12" font="1">Florencia Pauli</text>
<text top="215" left="121" width="85" height="12" font="1">RUNX3_(SC-101553)</text>
<text top="215" left="339" width="29" height="12" font="1">RUNX3</text>
<text top="170" left="230" width="25" height="12" font="1">Myers</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="485" left="361" width="28" height="12" font="1">Mouse</text>
<text top="300" left="395" width="26" height="12" font="1">B0909</text>
<text top="300" left="215" width="42" height="12" font="1">sc-101553</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="356" width="50" height="12" font="2">Monoclonal</text>
<text top="413" left="94" width="440" height="12" font="1">Member of the runt domain-containing family of transcription factors. A heterodimer of this protein and a </text>
<text top="425" left="94" width="440" height="12" font="1">beta subunit forms a complex that binds to the core DNA sequence 5'-PYGPYGGT-3' found in a number of </text>
<text top="437" left="94" width="316" height="12" font="1">enhancers and promoters, and can either activate or suppress transcription. </text>
<text top="449" left="94" width="124" height="12" font="1">Entrez gene ID 864; 46-48 kDa</text>
<text top="599" left="238" width="171" height="12" font="1">http://www.scbt.com/datasheet-101553-</text>
<text top="611" left="238" width="119" height="12" font="1">runx3-r3-5g4-antibody.html </text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="68" left="125" width="95" height="12" font="1">Western blot protocol: </text>
<text top="80" left="125" width="428" height="12" font="1">Whole cell lysate was immunoprecipitated using primary antibody, and the IP fraction was loaded on a </text>
<text top="92" left="125" width="422" height="12" font="1">12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, the samples </text>
<text top="104" left="125" width="422" height="12" font="1">were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.  Blotting with primary </text>
<text top="116" left="125" width="422" height="12" font="1">(same as that used for IP) and secondary HRP-conjugated antibodies was performed on an Invitrogen </text>
<text top="128" left="125" width="414" height="12" font="1">BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution (Thermo </text>
<text top="140" left="125" width="47" height="12" font="1">Scientific).  </text>
<text top="152" left="125" width="2" height="12" font="1"> </text>
<text top="164" left="125" width="418" height="12" font="1">Results: Band of expected size visualized, representing strongest signal in the lane.  The ~50 kDa and </text>
<text top="176" left="125" width="434" height="12" font="1">~45 kDa bands were both tested with IP-mass spec.  Only the ~45kDa band was positive for RUNX3.  See </text>
<text top="188" left="125" width="53" height="12" font="1">validation 2. </text>
<text top="200" left="125" width="2" height="12" font="1"> </text>
<text top="212" left="125" width="421" height="12" font="1">Figure legend: IP-western with sc-101553 in whole cell lysate (WCL) of GM12878; PM=protein marker. </text>
<text top="224" left="125" width="107" height="12" font="1">RUNX3 band is indicated. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="93" left="130" width="144" height="12" font="1">IP followed by mass spectrometry: </text>
<text top="105" left="130" width="404" height="12" font="1">Briefly, GM12878 whole cell lysates were immunoprecipitated using primary antibody, and the IP </text>
<text top="117" left="130" width="418" height="12" font="1">fraction was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. Gel </text>
<text top="129" left="130" width="419" height="12" font="1">was stained with Coomassie Blue in order to visualize marker bands. Gel fragments corresponding to </text>
<text top="141" left="130" width="397" height="12" font="1">the bands indicated above in the western blot image were excised and sent to the University of </text>
<text top="153" left="130" width="403" height="12" font="1">Alabama at Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the </text>
<text top="165" left="130" width="415" height="12" font="1">samples were run on an LTQ XL Linear Ion Trap Mass Spectrometer by LC-ESI-MS/MS. Peptides were </text>
<text top="177" left="130" width="423" height="12" font="1">identified using SEQUEST tandem mass spectra analysis, with probability based matching at p &lt; 0.05.  </text>
<text top="189" left="130" width="2" height="12" font="1"> </text>
<text top="201" left="130" width="268" height="12" font="1">As per ENCODE data standards, all SEQUEST results are attached </text>
<text top="213" left="130" width="400" height="12" font="1">(ENCODE_HAIB_RUNX3_ss101553_09262011_MassSpec.pdf), including common contaminants. </text>
<text top="225" left="130" width="420" height="12" font="1">Target protein, RUNX3, is listed as hit 3a in the ~45 kDa band.  The ~50 kDa band shown in Validation </text>
<text top="237" left="130" width="345" height="12" font="1">1 was also tested by mass spec and was positive for heavy chain, but not for RUNX3</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="3" size="8" family="Times" color="#000000"/>
<text top="138" left="57" width="34" height="12" font="3"><b>Entry </b></text>
<text top="151" left="57" width="18" height="12" font="3"><b>no.</b></text>
<text top="151" left="95" width="41" height="12" font="3"><b>Protein</b></text>
<text top="138" left="217" width="52" height="12" font="3"><b>Pprotein </b></text>
<text top="151" left="217" width="61" height="12" font="3"><b>probability</b></text>
<text top="112" left="285" width="47" height="12" font="3"><b>Percent </b></text>
<text top="125" left="285" width="50" height="12" font="3"><b>share of </b></text>
<text top="138" left="285" width="57" height="12" font="3"><b>spectrum </b></text>
<text top="151" left="285" width="20" height="12" font="3"><b>id's</b></text>
<text top="151" left="345" width="65" height="12" font="3"><b>Description</b></text>
<text top="177" left="57" width="14" height="12" font="3"><b>3a</b></text>
<text top="177" left="95" width="109" height="12" font="3"><b>UniRef100_B1AJV5</b></text>
<text top="177" left="275" width="7" height="12" font="3"><b>1</b></text>
<text top="177" left="323" width="18" height="12" font="3"><b>4.6</b></text>
<text top="164" left="345" width="199" height="12" font="3"><b>Runt-related transcription factor 3 </b></text>
<text top="177" left="344" width="89" height="12" font="3"><b>RUNX3_HUMAN</b></text>
<text top="190" left="57" width="12" height="12" font="1">4a</text>
<text top="190" left="95" width="102" height="12" font="1">UniRef100_B4DHM5</text>
<text top="190" left="275" width="6" height="12" font="1">1</text>
<text top="190" left="318" width="155" height="12" font="1">0.38 Phosphoglycerate kinase </text>
<text top="203" left="57" width="12" height="12" font="1">5a</text>
<text top="203" left="95" width="101" height="12" font="1">UniRef100_B4DUU6</text>
<text top="203" left="275" width="6" height="12" font="1">1</text>
<text top="203" left="318" width="110" height="12" font="1">0.93 Pyruvate kinase </text>
<text top="216" left="57" width="12" height="12" font="1">6a</text>
<text top="216" left="95" width="99" height="12" font="1">UniRef100_C5IWV5</text>
<text top="216" left="275" width="6" height="12" font="1">1</text>
<text top="216" left="318" width="91" height="12" font="1">10.6 Trypsinogen </text>
<text top="229" left="57" width="12" height="12" font="1">7a</text>
<text top="229" left="95" width="97" height="12" font="1">UniRef100_P02769</text>
<text top="229" left="275" width="6" height="12" font="1">1</text>
<text top="229" left="325" width="101" height="12" font="1">4.5 Serum albumin </text>
<text top="242" left="57" width="12" height="12" font="1">8a</text>
<text top="242" left="95" width="97" height="12" font="1">UniRef100_P04264</text>
<text top="242" left="275" width="6" height="12" font="1">1</text>
<text top="242" left="312" width="187" height="12" font="1">13.42 Keratin, type II cytoskeletal 1 </text>
<text top="255" left="57" width="13" height="12" font="1">8b</text>
<text top="255" left="95" width="97" height="12" font="1">UniRef100_P35908</text>
<text top="255" left="275" width="6" height="12" font="1">1</text>
<text top="255" left="318" width="235" height="12" font="1">5.19 Keratin, type II cytoskeletal 2 epidermal </text>
<text top="268" left="57" width="12" height="12" font="1">9a</text>
<text top="268" left="95" width="97" height="12" font="1">UniRef100_P13645</text>
<text top="268" left="275" width="6" height="12" font="1">1</text>
<text top="268" left="318" width="183" height="12" font="1">8.82 Keratin, type I cytoskeletal 10 </text>
<text top="281" left="57" width="13" height="12" font="1">9b</text>
<text top="281" left="95" width="97" height="12" font="1">UniRef100_P35527</text>
<text top="281" left="275" width="6" height="12" font="1">1</text>
<text top="281" left="318" width="176" height="12" font="1">6.26 Keratin, type I cytoskeletal 9 </text>
<text top="294" left="57" width="12" height="12" font="1">9c</text>
<text top="294" left="95" width="97" height="12" font="1">UniRef100_P02533</text>
<text top="294" left="275" width="6" height="12" font="1">1</text>
<text top="294" left="318" width="183" height="12" font="1">0.85 Keratin, type I cytoskeletal 14 </text>
<text top="307" left="57" width="19" height="12" font="1">10a</text>
<text top="307" left="95" width="97" height="12" font="1">UniRef100_P19474</text>
<text top="307" left="275" width="6" height="12" font="1">1</text>
<text top="307" left="318" width="122" height="12" font="1">5.54 52 kDa Ro protein </text>
<text top="333" left="57" width="19" height="12" font="1">11a</text>
<text top="333" left="95" width="100" height="12" font="1">UniRef100_Q4R4H6</text>
<text top="333" left="275" width="6" height="12" font="1">1</text>
<text top="333" left="312" width="29" height="12" font="1">14.97</text>
<text top="320" left="344" width="201" height="12" font="1">Brain cDNA, clone: QflA-11253, similar </text>
<text top="333" left="344" width="179" height="12" font="1">to human actin, gamma 1 (ACTG1)</text>
<text top="346" left="57" width="19" height="12" font="1">11b</text>
<text top="346" left="95" width="99" height="12" font="1">UniRef100_Q562R1</text>
<text top="346" left="275" width="6" height="12" font="1">1</text>
<text top="346" left="325" width="147" height="12" font="1">3.1 Beta-actin-like protein 2 </text>
<text top="359" left="57" width="18" height="12" font="1">11c</text>
<text top="359" left="95" width="99" height="12" font="1">UniRef100_P0CG39</text>
<text top="359" left="275" width="6" height="12" font="1">1</text>
<text top="359" left="325" width="220" height="12" font="1">1.6 POTE ankyrin domain family member J </text>
<text top="372" left="57" width="19" height="12" font="1">11d</text>
<text top="372" left="95" width="99" height="12" font="1">UniRef100_P0CG38</text>
<text top="372" left="275" width="6" height="12" font="1">1</text>
<text top="372" left="318" width="227" height="12" font="1">2.31 POTE ankyrin domain family member I </text>
<text top="385" left="57" width="13" height="12" font="1">12</text>
<text top="385" left="95" width="97" height="12" font="1">UniRef100_P00762</text>
<text top="385" left="246" width="36" height="12" font="1">0.9999</text>
<text top="385" left="318" width="116" height="12" font="1">0.36 Anionic trypsin-1 </text>
<text top="411" left="57" width="13" height="12" font="1">13</text>
<text top="411" left="95" width="97" height="12" font="1">UniRef100_P22695</text>
<text top="411" left="246" width="36" height="12" font="1">0.9864</text>
<text top="411" left="318" width="23" height="12" font="1">0.19</text>
<text top="398" left="344" width="191" height="12" font="1">Cytochrome b-c1 complex subunit 2, </text>
<text top="411" left="344" width="73" height="12" font="1">mitochondrial </text>
<text top="437" left="57" width="13" height="12" font="1">14</text>
<text top="437" left="95" width="102" height="12" font="1">UniRef100_B4DMU8</text>
<text top="437" left="246" width="36" height="12" font="1">0.9837</text>
<text top="437" left="318" width="23" height="12" font="1">0.19</text>
<text top="424" left="344" width="211" height="12" font="1">cDNA FLJ53063, highly similar to Tubulin </text>
<text top="437" left="344" width="67" height="12" font="1">beta-7 chain </text>
<text top="450" left="57" width="13" height="12" font="1">15</text>
<text top="450" left="95" width="97" height="12" font="1">UniRef100_P01625</text>
<text top="450" left="253" width="29" height="12" font="1">0.959</text>
<text top="450" left="318" width="188" height="12" font="1">0.56 Ig kappa chain V-IV region Len </text>
<text top="73" left="57" width="495" height="12" font="3"><b>Validation 2: RUNX3_(SC-101553)</b>.  Results of IP-Mass Spec for the ~45 kDa band identified </text>
<text top="86" left="57" width="452" height="12" font="1">in IP-Western from Validation 1.  The target protein, RUNX3, is identified in entry no. 3a.</text>
</page>
</pdf2xml>
